Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$20,000.00

Removal mechanisms, nature and relative toxicity of transformation products of pharmaceuticals in advanced wastewater treatment

EF 2012-13

Résumé
Hundreds of compounds including pharmaceuticals and endocrine disruptors have been identified in wastewaters in concentrations in the ug/L range while being detected in the ng/L range in surface waters. Traces of some of these compounds have also been detected in drinking water. Little information is available on the fate of these contaminants in the environment and in engineered systems but previous studies showed that conventional wastewater treatment approaches are not efficient at removing most of these compounds. Previous research conducted in my group showed that ozonation used as a tertiary treatment significantly enhance the removal of several of these compounds in municipal or industrial wastewaters. However, many questions remain: What is the nature of the transformation products? What are the most efficient oxidative approaches for the treatment of industrial wastewaters? What are the risks associated with the release of these transformation products in the environment? The long term objectives of the proposed research, supported by a state-of-the-art infrastructure obtained with the support of two grants awarded by the Canada Foundation for Innovation (Leaders Opportunity and New Initiatives Funds) are: 1) To improve our knowledge of the factors affecting the biodegradability of pharmaceuticals in the environment, 2) To assessing the efficiency and impact of ozonation of municipal wastewater on the fate of pharmaceuticals as well as the residual toxicity of the treated water and 3) To study other oxidative treatment approaches for the treatment of wastewaters from the pharmaceuticals industry in order to prioritize actions, established sound regulations and develop strategies to protect the environment and public health. The methodology proposed will result in the training of graduate students; will strengthen collaboration developed with toxicologists as well as with the pharmaceutical industry and wastewater treatment plants in Quebec. A better understanding and control of the removal mechanisms of these compounds will mitigate the risks associated with their presence in the environment.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
312545-2010
Name nom
Yargeau, Viviane
Department département
Chemical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1509
Committee name en
Civil, Industrial and Systems Engineering
Committee name fr
Génie civil, industriel et des systèmes
Area of application code
400
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Environment
Area of application fr
Environnement
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
3
Nb partie
5
Application title
Removal mechanisms, nature and relative toxicity of transformation products of pharmaceuticals in advanced wastewater treatment
Keyword
NSERC
Application summary
Hundreds of compounds including pharmaceuticals and endocrine disruptors have been identified in wastewaters in concentrations in the ug/L range while being detected in the ng/L range in surface waters. Traces of some of these compounds have also been detected in drinking water. Little information is available on the fate of these contaminants in the environment and in engineered systems but previous studies showed that conventional wastewater treatment approaches are not efficient at removing most of these compounds. Previous research conducted in my group showed that ozonation used as a tertiary treatment significantly enhance the removal of several of these compounds in municipal or industrial wastewaters. However, many questions remain: What is the nature of the transformation products? What are the most efficient oxidative approaches for the treatment of industrial wastewaters? What are the risks associated with the release of these transformation products in the environment? The long term objectives of the proposed research, supported by a state-of-the-art infrastructure obtained with the support of two grants awarded by the Canada Foundation for Innovation (Leaders Opportunity and New Initiatives Funds) are: 1) To improve our knowledge of the factors affecting the biodegradability of pharmaceuticals in the environment, 2) To assessing the efficiency and impact of ozonation of municipal wastewater on the fate of pharmaceuticals as well as the residual toxicity of the treated water and 3) To study other oxidative treatment approaches for the treatment of wastewaters from the pharmaceuticals industry in order to prioritize actions, established sound regulations and develop strategies to protect the environment and public health. The methodology proposed will result in the training of graduate students; will strengthen collaboration developed with toxicologists as well as with the pharmaceutical industry and wastewater treatment plants in Quebec. A better understanding and control of the removal mechanisms of these compounds will mitigate the risks associated with their presence in the environment.